CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 500 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $318,000 | +34.2% | 4,200 | +98.4% | 0.01% | +33.3% |
| Q3 2021 | $237,000 | -30.7% | 2,117 | +0.1% | 0.01% | -40.0% |
| Q2 2021 | $342,000 | +165.1% | 2,115 | +37.6% | 0.01% | +66.7% |
| Q3 2020 | $129,000 | -64.6% | 1,537 | -68.9% | 0.01% | -70.0% |
| Q2 2020 | $364,000 | +3.7% | 4,950 | -33.5% | 0.02% | +17.6% |
| Q2 2019 | $351,000 | +17.8% | 7,446 | +46.6% | 0.02% | -10.5% |
| Q2 2018 | $298,000 | -41.5% | 5,078 | -54.4% | 0.02% | -48.6% |
| Q1 2018 | $509,000 | -13.6% | 11,131 | -55.7% | 0.04% | -21.3% |
| Q4 2017 | $589,000 | – | 25,106 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |